Related Experiment Video
Updated: Aug 14, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis
J Alwakeel1, A M Gader, S Hurieb
1Department of Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia.
Insights
Continuous ambulatory peritoneal dialysis (CAPD) patients show higher coagulation inhibitors than hemodialysis (HD) patients, suggesting a protective mechanism against thrombosis in both dialysis groups despite differences in inhibitor levels.
Area of Science:
- Nephrology
- Hematology
- Clinical Chemistry
Background:
- Dialysis patients often experience altered coagulation and fibrinolysis.
- Understanding these changes is crucial for managing thrombotic risk.
Purpose of the Study:
- To compare coagulation inhibitors and fibrinolytic parameters in patients undergoing CAPD versus HD.
- To assess the impact of different dialysis modalities on hemostasis.
Main Methods:
- Assessed levels of Antithrombin III (ATIII), Proteins C and S, tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI).
- Compared parameters between 12 CAPD patients, 10 HD patients, and healthy controls.
Main Results:
- CAPD patients had higher ATIII, Protein C, and Protein S than HD patients.
- HD patients showed significantly lower ATIII and Protein C compared to controls.
- Both CAPD and HD patients exhibited higher tPA levels than controls, with no significant difference in PAI levels between patient groups and controls.
Conclusions:
- Hemodialysis is associated with a significant decrease in circulating coagulation inhibitors.
- Continuous ambulatory peritoneal dialysis patients maintain elevated levels of these inhibitors.
- Enhanced fibrinolysis in both groups may represent a compensatory mechanism against thrombotic tendencies.
Abstract:
Coagulation inhibitors and fibrinolytic parameters were studied in twelve patients on continuous ambulatory peritoneal dialysis (CAPD) and ten patients on haemodialysis (HD). Patients on CAPD exhibited higher levels of ATIII and proteins C and S than those on HD. No significant differences were noted in tPA and PAI levels. Both groups of patients showed higher levels of tPA than controls. Besides, patients on HD had significantly lower levels of ATIII and protein C than controls. PAI levels in both patient groups were similar to those of the controls, but tPA levels were higher in patients than in controls. These results indicate that HD is associated with marked diminution in the circulating levels of coagulation inhibitors. This is in contrast to CAPD patients who showed elevated levels of these inhibitors, despite their significant loss in the dialysate. The finding of enhanced fibrinolysis in both patient groups may be a natural protective mechanism against the development of a thrombotic tendency.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Venous Thrombosis III: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis II: Procedure and Complications
Acute Kidney Injury V: Interprofessional Care

